Skip to main content
. 2020 May 11;11(5):348. doi: 10.1038/s41419-020-2525-x

Fig. 5. Overexpression of FTSJ1 inhibited NSCLC tumor growth in vivo.

Fig. 5

PC9 cells stably expressed FTSJ1 or NC were used for in vivo study. a Growth curves of tumors in nude mice injected with stably expressed FTSJ1 of PC9 cells or control cells. b Images of xenografts derived from PC9 cells infected with lenti-FTSJ1 (upper panel) or lenti-NC (lower panel). c Tumor weight of xenografts derived from PC9 cells infected with lenti-FTSJ1 or controls. d Tumors developed from FTSJ1-overexpression cells revealed lower Ki-76 protein and higher TUNEL staining levels than that of tumors developed by lenti-NC cells, Ki-67 immunostaining; right, TUNEL staining. e qRT-PCR analysis showed that the expression level of FTSJ1 in lenti-FTSJ1-treated tumors was higher than that in lenti-NC-treated xenografts. All experiments were performed in biological triplicates with three technical replicates. Data are presented as mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001.